RiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial

BACKGROUND: Hepatic encephalopathy (HE) is a clinically significant complication of liver cirrhosis impacting on the patients’ quality of life. Minimal hepatic encephalopathy (MHE) is diagnosed by psychometric tests, found in up to 80 % of patients with liver cirrhosis and carries a high risk of pro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Schulz, Christian, Schütte, Kerstin, Kropf, Siegfried, Schmitt, Friedhelm C., Vasapolli, Riccardo, Kliegis, Leon M., Riegger, Antonia, Malfertheiner, Peter
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770677/
https://ncbi.nlm.nih.gov/pubmed/26926775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1205-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky